In summary, we report the prevalence and clinical significance of anti‐CRT Ab in a large cohort of adult‐onset IIM patients and reveal the possible association of anti‐CRT Ab with the occurrence of malignancy in IIM patients. This evidence concerns the gene CALR and acquired idiopathic inflammatory myopathy.